Loading clinical trials...
Loading clinical trials...
A Phase I Clinical Study on Absorption, Metabolism, and Excretion of [14C]HSK21542 in Healthy Adult Male Chinese Subjects - Mass Balance and Biotransformation of [14C]HSK21542 in Human.
Conditions
Interventions
[14C]HSK21542
Locations
1
China
f the First Affiliated Hospital of soochow University
Suzhou, Jiangsu, China
Start Date
June 15, 2021
Primary Completion Date
September 10, 2021
Completion Date
December 20, 2021
Last Updated
April 28, 2023
Lead Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions